6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine

Catalog No.: 
ACBOFE896
CAS No.: 
1208082-91-0
Molecular Formula: 
C7H5Br2N3
Molecular Weight: 
290.95
6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$53.00In stockInquiry
5g95%$173.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine
IUPAC Name6,8-dibromo-2-methylimidazo[1,2-a]pyrazine
MDL No.MFCD12406119
Molecular FormulaC7H5Br2N3
Molecular Weight290.95
SMILESCC1=CN2C(C(Br)=NC(Br)=C2)=N1
InChI KeyVBOLRIOORWFVNK-UHFFFAOYSA-N
Synonym6,8-Dibromo-2-methylimidazo[1,2-a]pyrazine;Imidazo[1,2-a]pyrazine, 6,8-dibromo-2-methyl-
CAS No.1208082-91-0
PubChem CID45789816

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBOFE896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBOFE896 route product structure diagram
    ACBOFE8961208082-91-0In Stock
Inquiry

2. ACBOFE896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBOFE896 route compound structure diagram
    ACBOFE8961208082-91-0In Stock
  4. Then
  5. ACBOFE896 route product structure diagram
    ACBOFE8961208082-91-0In Stock
Inquiry

3. ACBOFE896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBOFE896 route product structure diagram
    ACBOFE8961208082-91-0In Stock
Inquiry

Comments (0)